FRONTEO Opens 'KIBIT AI Biology Lab,' Its Own AI Drug Discovery Center
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
FRONTEO Inc. has opened the 'KIBIT AI Biology Lab,' a hub for its AI-powered drug discovery. This facility will be central to its four AI drug discovery businesses and academic collaborations, focusing on target molecule identification and hypothesis generation to accelerate the development of new drugs for rare diseases and cancer, aiming to create non-linear revenue opportunities through licensing out to pharmaceutical companies.